Meisel A, Annane D, Vu T, Mantegazza R, et al. Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension. J Neurol 2023 Apr 27. doi: 10.1007/s00415-023-11699.
PMID: 37103755